XOMASMALL

XOMA Royalty Corp.

HealthcareBiotechnology
$43.89
$0.00(+0.09%)
52W$22.29
$44.01
Updated Jul 8, 02:00 AM
RSI81
RS Rating85/99
Beta0.93
Volatility52%
F-Score5/9
Mkt Cap$550M
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

XOMA Royalty Corp. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 85), indicating clear outperformance against the broad market. Earnings growth of 151% provides fundamental context to the price action. However, with RSI at 81, the stock is extended and may be prone to a short-term pullback.

Relative Strength
85
out of 99
Market Leader
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
0.93
vs S&P 500
MARKET
52W Position
99%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$41.81
50 SMA > 100 SMA$36.04
100 SMA > 150 SMA$33.08
150 SMA > 200 SMA$33.57

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$42.25+3.87%ABOVE
50 SMA$41.81+4.98%ABOVE
100 SMA$36.04+21.78%ABOVE
150 SMA$33.08+32.66%ABOVE
200 SMA$33.57+30.73%ABOVE

Price Performance

1D+0.1%
1W+3.3%
1M+4.7%
3M+26.9%
6M+61.3%
YTD+56.8%
1Y+67.7%
3Y+38.0%
52-Week Trading Range99% from low
$43.89
52W Low$22.29
52W High$44.01

Technical Indicators

RSI (14)OVERBOUGHT
80.5
305070
Setup ScoreHOT
7/10
Base depth: 18.7%

Risk Profile

Beta
0.93
52W Vol
52%
ATR
$0.43
Max DD (1Y)
-42%

Volume Analysis

Today
144.6K
50D Avg
155.9K
Vol Ratio
0.93x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25-65%
$0.44
Q3'25+144%
$0.70
Q4'25+158%
$0.26
Q1'26+151%
$0.17
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:-0.61%
5 Years:+12.16%
3 Years:+105.30%
TTM:-3.33%

Compounded Profit Growth

10 Years:
5 Years:+13.36%
3 Years:
TTM:+317.39%

Stock Price CAGR

10 Years:+15.05%
5 Years:+5.66%
3 Years:+38.03%
1 Year:+67.71%

Return on Equity

10Y Avg:15.4%
5Y Avg:-3.9%
3Y Avg:-6.8%
Last Year:30.2%

Key Metrics

Market Cap$550M
Gross Margin94.3%
Net Margin60.8%
Piotroski F-Score5/9

Frequently Asked Questions

Is XOMA in an uptrend right now?

XOMA has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is XOMA overbought or oversold?

XOMA's RSI (14) is 81. The stock is in overbought territory (RSI > 70), which may signal a pullback.

Is XOMA outperforming the market?

XOMA has a Relative Strength (RS) Rating of 85 out of 99. Yes, XOMA is a market leader, outperforming 85% of all stocks over the past 12 months.

Where is XOMA in its 52-week range?

XOMA is trading at $43.89, which is 100% of its 52-week high ($44.01) and 99% above its 52-week low ($22.29).

How volatile is XOMA?

XOMA has a Beta of 0.93 and 52-week volatility of 52%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.